Alina Henn

Genetikum

Papers

1

Total Citations

8

H-Index

1

About

Alina Henn is a dedicated surgical oncologist whose research focuses on advancing the treatment of urothelial bladder carcinoma, particularly through the comparative analysis of surgical techniques. Her key contributions center on evaluating the oncological outcomes of robot-assisted radical cystectomy (RARC) versus open surgery, a critical area in urological oncology. Her most-cited work, a 2018 study comparing 2-year oncological outcomes and early recurrence patterns in patients undergoing these procedures, has garnered 8 citations, providing valuable insights into the safety and efficacy of minimally invasive approaches. This research addresses a significant gap in the literature, as data on long-term oncological follow-up after RARC were previously scarce, and it helps clarify concerns about potential increases in early or atypical recurrences. By meticulously analyzing clinical data from 89 RARC patients against 59 open surgery cases, Henn has contributed to evidence-based decision-making in surgical oncology. Her work is particularly notable for its practical implications, guiding surgeons in optimizing patient outcomes and recurrence monitoring. Alina Henn’s research underscores her commitment to improving cancer care through rigorous comparative studies, making her a respected voice in the field of urological oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of 2-Year Oncological Outcome and Early Recurrence Patterns in Patients with Urothelial Bladder Carcinoma Treated with Open or Robot-Assisted Radical Cystectomy with an Extracorporeal Urinary Diversion
8 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Genetikum

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago